CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Clinical Trials Arena
Original article

Orum to begin Phase I trial of ORM-1153 after FDA clearance

Phase 1approvedORM-1153Positive
AI Analysis

Summary

The FDA has approved Orum Therapeutics' IND application for ORM-1153, enabling the initiation of a Phase 1 clinical trial.

Clinical Trial Data

Phase

Phase 1

Outcome Details

FDA approved IND application

Importance:5/10
Sentiment:
0.70
FDA approvalIND clearancePhase 1clinical trial
Related Companies

Read the original article

Published by Clinical Trials Arena on August 24, 2026 9:04 AM

Read Original